These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 17266927)
1. Role of microphthalmia transcription factor (Mitf) in melanoma differentiation. Lekmine F; Chang CK; Sethakorn N; Das Gupta TK; Salti GI Biochem Biophys Res Commun; 2007 Mar; 354(3):830-5. PubMed ID: 17266927 [TBL] [Abstract][Full Text] [Related]
2. Induction of microphthalmia transcription factor (Mitf) by forskolin and stimulation of melanin release in UISO-Mel-6 cells. Lekmine F; Salti GI J Surg Res; 2008 Sep; 149(1):27-30. PubMed ID: 18028952 [TBL] [Abstract][Full Text] [Related]
3. The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma. Selzer E; Wacheck V; Lucas T; Heere-Ress E; Wu M; Weilbaecher KN; Schlegel W; Valent P; Wrba F; Pehamberger H; Fisher D; Jansen B Cancer Res; 2002 Apr; 62(7):2098-103. PubMed ID: 11929831 [TBL] [Abstract][Full Text] [Related]
4. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Carreira S; Goodall J; Denat L; Rodriguez M; Nuciforo P; Hoek KS; Testori A; Larue L; Goding CR Genes Dev; 2006 Dec; 20(24):3426-39. PubMed ID: 17182868 [TBL] [Abstract][Full Text] [Related]
5. [Malignant melanoma and the role of the paradoxal protein Microphthalmia transcription factor]. Denat L; Larue L Bull Cancer; 2007 Jan; 94(1):81-92. PubMed ID: 17237008 [TBL] [Abstract][Full Text] [Related]
6. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells. Javelaud D; Alexaki VI; Pierrat MJ; Hoek KS; Dennler S; Van Kempen L; Bertolotto C; Ballotti R; Saule S; Delmas V; Mauviel A Pigment Cell Melanoma Res; 2011 Oct; 24(5):932-43. PubMed ID: 21801332 [TBL] [Abstract][Full Text] [Related]
7. Indole-3-carbinol and ultraviolet B induce apoptosis of human melanoma cells via down-regulation of MITF. Kim SY; Kima DS; Jeong YM; Moon SI; Kwon SB; Park KC Pharmazie; 2011 Dec; 66(12):982-7. PubMed ID: 22312706 [TBL] [Abstract][Full Text] [Related]
8. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression. Kim A; Yang Y; Lee MS; Yoo YD; Lee HG; Lim JS Pigment Cell Melanoma Res; 2008 Dec; 21(6):653-64. PubMed ID: 19067970 [TBL] [Abstract][Full Text] [Related]
9. Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells. Goodall J; Carreira S; Denat L; Kobi D; Davidson I; Nuciforo P; Sturm RA; Larue L; Goding CR Cancer Res; 2008 Oct; 68(19):7788-94. PubMed ID: 18829533 [TBL] [Abstract][Full Text] [Related]
10. SWI/SNF chromatin remodeling complex is critical for the expression of microphthalmia-associated transcription factor in melanoma cells. Vachtenheim J; Ondrusová L; Borovanský J Biochem Biophys Res Commun; 2010 Feb; 392(3):454-9. PubMed ID: 20083088 [TBL] [Abstract][Full Text] [Related]
11. Cooperative antiproliferative signaling by aspirin and indole-3-carbinol targets microphthalmia-associated transcription factor gene expression and promoter activity in human melanoma cells. Poindexter KM; Matthew S; Aronchik I; Firestone GL Cell Biol Toxicol; 2016 Apr; 32(2):103-19. PubMed ID: 27055402 [TBL] [Abstract][Full Text] [Related]
12. Role of microphthalmia transcription factor in regulation of melanocyte differentiation marker TRP-1. Fang D; Setaluri V Biochem Biophys Res Commun; 1999 Mar; 256(3):657-63. PubMed ID: 10080955 [TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells. Buscà R; Berra E; Gaggioli C; Khaled M; Bille K; Marchetti B; Thyss R; Fitsialos G; Larribère L; Bertolotto C; Virolle T; Barbry P; Pouysségur J; Ponzio G; Ballotti R J Cell Biol; 2005 Jul; 170(1):49-59. PubMed ID: 15983061 [TBL] [Abstract][Full Text] [Related]
14. Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny. Cheli Y; Giuliano S; Botton T; Rocchi S; Hofman V; Hofman P; Bahadoran P; Bertolotto C; Ballotti R Oncogene; 2011 May; 30(20):2307-18. PubMed ID: 21278797 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells. Cheli Y; Giuliano S; Fenouille N; Allegra M; Hofman V; Hofman P; Bahadoran P; Lacour JP; Tartare-Deckert S; Bertolotto C; Ballotti R Oncogene; 2012 May; 31(19):2461-70. PubMed ID: 21996743 [TBL] [Abstract][Full Text] [Related]
16. Effect of 17 beta-estradiol on the growth of estrogen receptor-positive human melanoma in vitro and in athymic mice. Feucht KA; Walker MJ; Das Gupta TK; Beattie CW Cancer Res; 1988 Dec; 48(24 Pt 1):7093-101. PubMed ID: 3191486 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic RNA interference of malignant melanoma by electrotransfer of small interfering RNA targeting Mitf. Nakai N; Kishida T; Shin-Ya M; Imanishi J; Ueda Y; Kishimoto S; Mazda O Gene Ther; 2007 Feb; 14(4):357-65. PubMed ID: 17024102 [TBL] [Abstract][Full Text] [Related]
18. microRNA-155, induced by interleukin-1ß, represses the expression of microphthalmia-associated transcription factor (MITF-M) in melanoma cells. Arts N; Cané S; Hennequart M; Lamy J; Bommer G; Van den Eynde B; De Plaen E PLoS One; 2015; 10(4):e0122517. PubMed ID: 25853464 [TBL] [Abstract][Full Text] [Related]
19. Breast cancer suppressor candidate-1 (BCSC-1) is a melanoma tumor suppressor that down regulates MITF. Anghel SI; Correa-Rocha R; Budinska E; Boligan KF; Abraham S; Colombetti S; Fontao L; Mariotti A; Rimoldi D; Ghanem GE; Fisher DE; Lévy F; Delorenzi M; Piguet V Pigment Cell Melanoma Res; 2012 Jul; 25(4):482-7. PubMed ID: 22594792 [TBL] [Abstract][Full Text] [Related]
20. Cell cycle inhibitor p21/ WAF1/ CIP1 as a cofactor of MITF expression in melanoma cells. Sestáková B; Ondrusová L; Vachtenheim J Pigment Cell Melanoma Res; 2010 Apr; 23(2):238-51. PubMed ID: 20067556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]